Loading clinical trials...
Loading clinical trials...
The aim of this study is to evaluate the reduced incretin effect observed in patients with T2DM in relation to reversibility. The incretin effect will be measured by means of OGTT and iIVGTT in 12 wom...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Lodz
Collaborators
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT05569772 · Glucose Intolerance After a Recent History of Gestational Diabetes
NCT06883344 · Type 1 Diabetes (T1D), Pregnancy, and more
NCT06310356 · Gestational Diabetes
NCT06925815 · Healthy Pregnant Women, Obese Pregnant Women, and more
Departament of Diabetology and Metabolic Diseases, Polish Mothers Research Hospital
Lodz
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions